Guideline for clinical use of thalidomide for management of erythema nodosum leprosum in Japan-Reference-Cited by-同舟云学术

Guideline for clinical use of thalidomide for management of erythema nodosum leprosum in Japan

Published:2017 Issue:2 Volume:86 Page:91-100
ISSN:1342-3681
Container-title:JAPANESE JOURNAL OF LEPROSY
language:en
Short-container-title:Jpn.J.Leprosy

Author:

Ishii Norihisa¹,Ishida Yutaka²,Okano Yoshiko³,Ozaki Motoaki⁴,Gidoh Masaichi⁵,Kumano Kimiko⁶,Goto Masamichi⁷,Nogami Reiko⁸,Hatano Kentaro⁹,Yamada Akatsuki¹⁰,Yamaguchi Sayaka¹¹,Yotsu Rie Roselyne¹²

Affiliation:

1. Leprosy Research Center, National Institute of Infectious Diseases

2. Amakusa City Ushibuka Citizens’ Hospital

3. National Sanatorium Oshima-Seishoen

4. Department of Dermatology, Kyoto University Graduate School of Medicine

5. National Hansen’s Disease Museum

6. Hyogo Cancer Center

7. National Sanatorium Hoshizuka-Keiaien

8. National Sanatorium Kikuchi-Keifuen

9. National Sanatorium Oku-Komyoen

10. Tatsumi-Pharmacy

11. Ryukyu University

12. National Sanatorium Suruga, Shizuoka/Department of Dermatology, National Center for Global Health and Medicine

Publisher

Japanese Leprosy Association

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/hansen/86/2/86_91/_pdf

Reference29 articles.

1. 1) Nakajima H, Nagao E, Ozaki M, Ishii N: Guideline for the diagnosis and treatment of leprosy. pp 1-48, Ministry of Health and Welfare, 1997. [In Japanese]

2. 2) Kumano K: Leprosy reactions. Jpn J Lepr 71: 3-29, 2002. [In Japanese]

3. 3) Evaluation Committee on the Appropriate Use of Pharmaceuticals, Japanese Society of Clinical Hematology: Guideline on the use of thalidomide for the treatment of multiple myeloma (MHLW Program for Appropriate Use of Pharmaceuticals, 2003/2004). [In Japanese]

4. 4) Sheskin J: Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6: 303-306, 1965.

5. 5) Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeldis J, Siegel D, Crowley J, Barlogie B: Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341: 1565-1571, 1999.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in the Development of Thalidomide-Related Compounds as Anticancer Drugs;Current Medicinal Chemistry;2022-01

2. Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?;Expert Opinion on Drug Safety;2021-07-15

3. Rationale use of Thalidomide in erythema nodosum leprosum - A non-systematic critical analysis of published case reports;Revista da Sociedade Brasileira de Medicina Tropical;2020

4. Thalidomide;Reactions Weekly;2018-09